{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:37:17Z","timestamp":1775277437461,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Beijing Medical Award Foundation","award":["YXTL-2023-726-0158"],"award-info":[{"award-number":["YXTL-2023-726-0158"]}]},{"DOI":"10.13039\/501100020756","name":"Shanghai Professional Technology Service Platform on Cold Chain Equipment Performance and Energy Saving Evaluation","doi-asserted-by":"publisher","award":["ZH-YXJK-34"],"award-info":[{"award-number":["ZH-YXJK-34"]}],"id":[{"id":"10.13039\/501100020756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00066-024-02360-1","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T09:47:14Z","timestamp":1740563234000},"page":"645-655","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and toxicity of stereotactic radiotherapy combined with third-generation EGFR-TKIs and immunotherapy in patients with brain metastases from non-small cell lung cancer"],"prefix":"10.1007","volume":"201","author":[{"given":"Xiaoxuan","family":"Tao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qichang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nannan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuncheng","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"issue":"3","key":"2360_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung\u00a0H, Ferlay\u00a0J, Siegel\u00a0RL, Laversanne\u00a0M, Soerjomataram\u00a0I, Jemal\u00a0A, Bray\u00a0F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"2360_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw7999","author":"M Molina-Arcas","year":"2019","unstructured":"Molina-Arcas\u00a0M, Moore\u00a0C, Rana\u00a0S, van Maldegem\u00a0F, Mugarza\u00a0E, Romero-Clavijo\u00a0P, Herbert\u00a0E, Horswell\u00a0S, Li\u00a0LS, Janes\u00a0MR et\u00a0al (2019) Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aaw7999","journal-title":"Sci Transl Med"},{"issue":"2","key":"2360_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S2213-2600(23)00382-X","volume":"12","author":"A Hattori","year":"2024","unstructured":"Hattori\u00a0A, Suzuki\u00a0K, Takamochi\u00a0K, Wakabayashi\u00a0M, Sekino\u00a0Y, Tsutani\u00a0Y, Nakajima\u00a0R, Aokage\u00a0K, Saji\u00a0H, Tsuboi\u00a0M et\u00a0al (2024) Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802\/WJOG4607L): a\u00a0post-hoc supplemental analysis of a\u00a0multicentre, open-label, phase\u00a03\u00a0trial. Lancet Respir Med 12(2):105\u2013116","journal-title":"Lancet Respir Med"},{"issue":"1","key":"2360_CR4","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1038\/s41598-024-56046-w","volume":"14","author":"S Kahraman","year":"2024","unstructured":"Kahraman\u00a0S, Karakaya\u00a0S, Kaplan\u00a0MA, Goksu\u00a0SS, Ozturk\u00a0A, Isleyen\u00a0ZS, Hamdard\u00a0J, Yildirim\u00a0S, Dogan\u00a0T, Isik\u00a0S et\u00a0al (2024) Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases. Sci Rep 14(1):5820","journal-title":"Sci Rep"},{"issue":"3","key":"2360_CR5","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3390\/curroncol29030150","volume":"29","author":"H Mithoowani","year":"2022","unstructured":"Mithoowani\u00a0H, Febbraro\u00a0M (2022) Non-small-cell lung cancer in 2022: a\u00a0review for general practitioners in oncology. Curr Oncol 29(3):1828\u20131839","journal-title":"Curr Oncol"},{"issue":"10","key":"2360_CR6","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.jtho.2016.06.002","volume":"11","author":"J Khalifa","year":"2016","unstructured":"Khalifa\u00a0J, Amini\u00a0A, Popat\u00a0S, Gaspar\u00a0LE, Faivre-Finn\u00a0C (2016) Brain metastases from NSCLC: radiation therapy in the era of targeted therapies. J\u00a0Thorac Oncol 11(10):1627\u20131643","journal-title":"J Thorac Oncol"},{"issue":"9","key":"2360_CR7","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.jtho.2019.05.030","volume":"14","author":"J Rutkowski","year":"2019","unstructured":"Rutkowski\u00a0J, Saad\u00a0ED, Burzykowski\u00a0T, Buyse\u00a0M, Jassem\u00a0J (2019) Chronological trends in progression-free, overall, and post-progression survival in first-line therapy for advanced NSCLC. J\u00a0Thorac Oncol 14(9):1619\u20131627","journal-title":"J Thorac Oncol"},{"issue":"2","key":"2360_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1227\/01.NEU.0000249272.64439.B1","volume":"60","author":"EL Chang","year":"2007","unstructured":"Chang\u00a0EL, Wefel\u00a0JS, Maor\u00a0MH, Hassenbusch\u00a0SJ 3rd, Mahajan\u00a0A, Lang\u00a0FF, Woo\u00a0SY, Mathews\u00a0LA, Allen\u00a0PK, Shiu\u00a0AS et\u00a0al (2007) A\u00a0pilot study of neurocognitive function in patients with one to three new brain metastases initially treated with stereotactic radiosurgery alone. Neurosurgery 60(2):277\u2013283 (discussion 283\u2013274)","journal-title":"Neurosurgery"},{"issue":"1","key":"2360_CR9","first-page":"vdae040","volume":"6","author":"K Holikova","year":"2024","unstructured":"Holikova\u00a0K, Selingerova\u00a0I, Pospisil\u00a0P, Bulik\u00a0M, Hynkova\u00a0L, Kolouskova\u00a0I, Hnidakova\u00a0L, Burkon\u00a0P, Slavik\u00a0M, Sana\u00a0J et\u00a0al (2024) Hippocampal subfield volumetric changes after radiotherapy for brain metastases. Neurooncol Adv 6(1):vdae40","journal-title":"Neurooncol Adv"},{"issue":"1","key":"2360_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13014-023-02200-z","volume":"18","author":"L Kuntz","year":"2023","unstructured":"Kuntz\u00a0L, Le F\u00e8vre\u00a0C, Jarnet\u00a0D, Keller\u00a0A, Meyer\u00a0P, Thiery\u00a0A, Cebula\u00a0H, Noel\u00a0G, Antoni\u00a0D (2023) Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a\u00a0retrospective study of 184 patients. Radiat Oncol 18(1):21","journal-title":"Radiat Oncol"},{"issue":"9","key":"2360_CR11","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1080\/0284186X.2019.1633016","volume":"58","author":"D Hartgerink","year":"2019","unstructured":"Hartgerink\u00a0D, Swinnen\u00a0A, Roberge\u00a0D, Nichol\u00a0A, Zygmanski\u00a0P, Yin\u00a0FF, Deblois\u00a0F, Hurkmans\u00a0C, Ong\u00a0CL, Bruynzeel\u00a0A et\u00a0al (2019) LINAC based stereotactic radiosurgery for multiple brain metastases: guidance for clinical implementation. Acta Oncol 58(9):1275\u20131282","journal-title":"Acta Oncol"},{"issue":"6","key":"2360_CR12","doi-asserted-by":"publisher","first-page":"101054","DOI":"10.1016\/j.xcrm.2023.101054","volume":"4","author":"WH Hudson","year":"2023","unstructured":"Hudson\u00a0WH, Olson\u00a0JJ, Sudmeier\u00a0LJ (2023) Immune microenvironment remodeling after radiation of a\u00a0progressing brain metastasis. Cell Rep Med 4(6):101054","journal-title":"Cell Rep Med"},{"issue":"3","key":"2360_CR13","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.ijrobp.2023.09.020","volume":"118","author":"SH Jeon","year":"2024","unstructured":"Jeon\u00a0SH, Jang\u00a0BS, Kim\u00a0DY, Kim\u00a0JH, Shin\u00a0EC, Kim\u00a0IA (2024) Dynamic responses of circulating T cells after stereotactic body radiation therapy for bone metastasis in patients with breast cancer. Int J Radiat Oncol Biol Phys 118(3):790\u2013800","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"15","key":"2360_CR14","doi-asserted-by":"publisher","first-page":"e1484","DOI":"10.1212\/WNL.0000000000012642","volume":"97","author":"A Mansouri","year":"2021","unstructured":"Mansouri\u00a0A, Padmanaban\u00a0V, Aregawi\u00a0D, Glantz\u00a0M (2021) VEGF and immune checkpoint inhibition for prevention of brain metastases: systematic review and meta-analysis. Neurology 97(15):e1484\u2013e1492","journal-title":"Neurology"},{"issue":"1","key":"2360_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12967-023-04089-4","volume":"21","author":"W Tian","year":"2023","unstructured":"Tian\u00a0W, Chu\u00a0X, Tanzhu\u00a0G, Zhou\u00a0R (2023) Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basis. J\u00a0Transl Med 21(1):244","journal-title":"J Transl Med"},{"issue":"4","key":"2360_CR16","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1158\/1535-7163.MCT-23-0371","volume":"23","author":"T Ogimoto","year":"2024","unstructured":"Ogimoto\u00a0T, Ozasa\u00a0H, Tsuji\u00a0T, Funazo\u00a0T, Yamazoe\u00a0M, Hashimoto\u00a0K, Yoshida\u00a0H, Hosoya\u00a0K, Ajimizu\u00a0H, Nomizo\u00a0T et\u00a0al (2024) Combination therapy with EGFR tyrosine kinase inhibitors and TEAD inhibitor increases tumor suppression effects in EGFR mutation-positive lung cancer. Mol Cancer Ther 23(4):564\u2013576","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"2360_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11523-022-00941-7","volume":"18","author":"S Popat","year":"2023","unstructured":"Popat\u00a0S, Ahn\u00a0MJ, Ekman\u00a0S, Leighl\u00a0NB, Ramalingam\u00a0SS, Reungwetwattana\u00a0T, Siva\u00a0S, Tsuboi\u00a0M, Wu\u00a0YL, Yang\u00a0JC (2023) Osimertinib for EGFR-mutant non-small-cell lung cancer central nervous system metastases: current evidence and future perspectives on therapeutic strategies. Target Oncol 18(1):9\u201324","journal-title":"Target Oncol"},{"issue":"2","key":"2360_CR18","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3892\/ijo.2021.5168","volume":"58","author":"AK Vaid","year":"2021","unstructured":"Vaid\u00a0AK, Gupta\u00a0A, Momi\u00a0G (2021) Overall survival in stage\u00a0IV EGFR mutation-positive NSCLC: comparing first-, second- and third-generation EGFR-TKis (review). Int J Oncol 58(2):171\u2013184","journal-title":"Int J Oncol"},{"key":"2360_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aav6473","author":"Z Liu","year":"2019","unstructured":"Liu\u00a0Z, Han\u00a0C, Dong\u00a0C, Shen\u00a0A, Hsu\u00a0E, Ren\u00a0Z, Lu\u00a0C, Liu\u00a0L, Zhang\u00a0A, Timmerman\u00a0C et\u00a0al (2019) Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity. Sci Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.aav6473","journal-title":"Sci Immunol"},{"key":"2360_CR20","doi-asserted-by":"publisher","first-page":"216062","DOI":"10.1016\/j.canlet.2023.216062","volume":"556","author":"EK Kleczko","year":"2023","unstructured":"Kleczko\u00a0EK, Le\u00a0AT, Hinz\u00a0TK, Nguyen\u00a0TT, Navarro\u00a0A, Hu\u00a0CJ, Selman\u00a0AM, Clambey\u00a0ET, Merrick\u00a0DT, Lu\u00a0S et\u00a0al (2023) Novel EGFR-mutant mouse models of lung adenocarcinoma reveal adaptive immunity requirement for durable osimertinib response. Cancer Lett 556:216062","journal-title":"Cancer Lett"},{"key":"2360_CR21","doi-asserted-by":"publisher","first-page":"103431","DOI":"10.1016\/j.critrevonc.2021.103431","volume":"165","author":"F Gagliardi","year":"2021","unstructured":"Gagliardi\u00a0F, De Domenico\u00a0P, Snider\u00a0S, Roncelli\u00a0F, Pompeo\u00a0E, Barzaghi\u00a0LR, Bulotta\u00a0A, Gregorc\u00a0V, Lazzari\u00a0C, Cascinu\u00a0S et\u00a0al (2021) Role of stereotactic radiosurgery for the treatment of brain metastasis in the era of immunotherapy: a\u00a0systematic review on current evidences and predicting factors. Crit Rev Oncol Hematol 165:103431","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"2360_CR22","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1093\/neuonc\/noab129","volume":"23","author":"S Scoccianti","year":"2021","unstructured":"Scoccianti\u00a0S, Olmetto\u00a0E, Pinzi\u00a0V, Osti\u00a0MF, Di Franco\u00a0R, Caini\u00a0S, Anselmo\u00a0P, Matteucci\u00a0P, Franceschini\u00a0D, Mantovani\u00a0C et\u00a0al (2021) Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a\u00a0multicentric retrospective study on behalf of AIRO. Neuro Oncol 23(10):1750\u20131764","journal-title":"Neuro Oncol"},{"issue":"9","key":"2360_CR23","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/COC.0000000000000849","volume":"44","author":"H Uezono","year":"2021","unstructured":"Uezono\u00a0H, Nam\u00a0D, Kluger\u00a0HM, Sznol\u00a0M, Hurwitz\u00a0M, Yu\u00a0JB, Chiang\u00a0VL (2021) Outcomes of stereotactic radiosurgery and immunotherapy in renal cell carcinoma patients with brain metastases. Am J Clin Oncol 44(9):495\u2013501","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"2360_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41577-023-00973-8","volume":"24","author":"LH Butterfield","year":"2024","unstructured":"Butterfield\u00a0LH, Najjar\u00a0YG (2024) Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations. Nat Rev Immunol 24(6):399\u2013416","journal-title":"Nat Rev Immunol"},{"issue":"21","key":"2360_CR25","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1056\/NEJMoa2306434","volume":"389","author":"D Planchard","year":"2023","unstructured":"Planchard\u00a0D, J\u00e4nne\u00a0PA, Cheng\u00a0Y, Yang\u00a0JC, Yanagitani\u00a0N, Kim\u00a0SW, Sugawara\u00a0S, Yu\u00a0Y, Fan\u00a0Y, Geater\u00a0SL et\u00a0al (2023) Osimertinib with or without chemotherapy in EGFR-mutated advanced NSCLC. N\u00a0Engl J Med 389(21):1935\u20131948","journal-title":"N Engl J Med"},{"issue":"2","key":"2360_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1634\/theoncologist.2015-0293","volume":"21","author":"FY Moraes","year":"2016","unstructured":"Moraes\u00a0FY, Taunk\u00a0NK, Marta\u00a0GN, Suh\u00a0JH, Yamada\u00a0Y (2016) The rationale for targeted therapies and stereotactic radiosurgery in the treatment of brain metastases. Oncologist 21(2):244\u2013251","journal-title":"Oncologist"},{"key":"2360_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13236086","author":"M Loo","year":"2021","unstructured":"Loo\u00a0M, Clavier\u00a0JB, Attal Khalifa\u00a0J, Moyal\u00a0E, Khalifa\u00a0J (2021) Dose-response effect and dose-toxicity in stereotactic radiotherapy for brain metastases: a\u00a0review. Cancers. https:\/\/doi.org\/10.3390\/cancers13236086","journal-title":"Cancers"},{"issue":"1","key":"2360_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge\u00a0WM (2005) The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2(1):3\u201314","journal-title":"NeuroRx"},{"issue":"14","key":"2360_CR29","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.7150\/thno.42234","volume":"10","author":"W Yin","year":"2020","unstructured":"Yin\u00a0W, Zhao\u00a0Y, Kang\u00a0X, Zhao\u00a0P, Fu\u00a0X, Mo\u00a0X, Wang\u00a0Y, Huang\u00a0Y (2020) BBB-penetrating codelivery liposomes treat brain metastasis of non-small cell lung cancer with EGFR(T790M) mutation. Theranostics 10(14):6122\u20136135","journal-title":"Theranostics"},{"issue":"1","key":"2360_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1158\/1078-0432.CCR-19-1871","volume":"27","author":"N Colclough","year":"2021","unstructured":"Colclough\u00a0N, Chen\u00a0K, Johnstr\u00f6m\u00a0P, Strittmatter\u00a0N, Yan\u00a0Y, Wrigley\u00a0GL, Schou\u00a0M, Goodwin\u00a0R, Varn\u00e4s\u00a0K, Adua\u00a0SJ et\u00a0al (2021) Preclinical comparison of the blood-brain barrier permeability of osimertinib with other EGFR TKis. Clin Cancer Res 27(1):189\u2013201","journal-title":"Clin Cancer Res"},{"issue":"21","key":"2360_CR31","doi-asserted-by":"publisher","first-page":"5557","DOI":"10.1158\/1078-0432.CCR-19-2300","volume":"26","author":"JS Bergholz","year":"2020","unstructured":"Bergholz\u00a0JS, Wang\u00a0Q, Kabraji\u00a0S, Zhao\u00a0JJ (2020) Integrating immunotherapy and targeted therapy in cancer treatment: mechanistic insights and clinical implications. Clin Cancer Res 26(21):5557\u20135566","journal-title":"Clin Cancer Res"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-024-02360-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-024-02360-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-024-02360-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T13:46:41Z","timestamp":1748440001000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-024-02360-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2360"],"URL":"https:\/\/doi.org\/10.1007\/s00066-024-02360-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]},"assertion":[{"value":"19 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"X.\u00a0Tao, Q.\u00a0Gao, Y.\u00a0Chen, N.\u00a0Cai and C.\u00a0Hao declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The Ethics Committee of Harbin Medical University reviewed and approved this study. The included patient treatment details and imaging photographs were accompanied by written informed consent, signed by either the patients themselves or their relatives.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}